Xylem (XYL) ebitda was $1.9B in FY2025 (+16% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$1.9B
+16%
2024
$1.7B
+38%
2023
$1.2B
+34%
2022
$910M
+5%
2021
$869M
+24%
2020
$698M
-15%
2019
$825M
-15%
2018
$965M
+17%
2017
$827M
+36%
2016
$607M
+1%
2015
$603M
-7%
2014
$649M
+12%
2013
$580M
-7%
2012
$624M
+14%
2011
$545M
+9%
2010
$502M
+30%
2009
$386M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$488M
Q1 2026
$353M
Q4 2025
$776M
Q3 2025
$455M
Q2 2025
$416M
Q1 2025
$315M
Q4 2024
$670M
Q3 2024
$369M
Q2 2024
$372M
Q1 2024
$289M
Q4 2023
$364M
Q3 2023
$376M
Source: XYL on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.